Skip to content
Search

Latest Stories

CCA submits evidence to 10-year plan, calls for action on funding and barriers

CCA urges policymakers to address funding crisis, barriers hindering community pharmacies
gettyimages

Each pharmacy in England suffers a funding shortfall of £100,000 every year 

Community pharmacy is integral to accelerating the three shifts envisaged by the government, but concrete action is needed to address the current funding crisis -  the Company Chemists’ Association (CCA) has stated in its response to the 10-year plan consultation.

The CCA highlighted a wide range of pharmacy services that could contribute to achieving the government’s vision shifting care from hospitals to community, from analogue to digital, and from treating sickness to prevention.


To strengthen the sector's role in prevention, it proposes expanding the pharmacy’s role in vaccination, screening, emergency hormonal contraception (EHC), and smoking cessation services.

Furthermore, the CCA’s submission noted that the expansion of Pharmacy First as “key to moving more care into the community.”

As of October 2024, pharmacies provided 1.4 million urgent care consultations for conditions that would have otherwise been treated elsewhere in the NHS, according to the organisation, which also estimates that an expanded Pharmacy First service could free up over 30 million GP appointments each year.

However, the CCA argued that the rollout of these services and additional workload by pharmacies is only possible if “the existing funding black hole is addressed.”

Malcolm Harrison, chief executive of the CCA said: “Pharmacies are absolutely integral to delivering the shifts to prevention and care closer to the community.

“The network is ready to do even more – but the foundations need fixing.”

He pointed out that each pharmacy in England is now suffering a funding shortfall of £100,000 every year.

“Policymakers must, urgently, remedy the funding crisis,” Harrison noted, emphasising that continued underfunding is hindering businesses from being able to invest in the innovative services and practices that patients need.

“Any action on funding needs to go hand-in-hand with action to address the workforce challenges, updating outdated regulation, and ensuring commissioning provides patients in different postcodes with a universal offer,” he added.

In addition to core funding, Policymakers are also urged to address the "barriers" hindering community pharmacies. These include continued ARRS recruitment, which is depleting the community pharmacy workforce, and a lack of planning to harness independent prescribing and upskill the existing pharmacist workforce to become prescribers.

The CCA also highlighted the postcode lottery of commissioning, which creates “unnecessary legal, financial and administrative inefficiencies for pharmacy businesses that operate across regional boundaries.”

According to the association, outdated regulation is failing to make the best use of the skill mix within pharmacy teams, limiting pharmacists to dispensing and related tasks.

Finally, the CCA pointed out the insufficient integration of patient records and the lack of interoperability between general practice and community pharmacy.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less